Zaidman GW, Flanagan JK, Furey CC. Long-term visual prognosis in children after corneal transplant surgery for Peters anomaly type I. Am J Ophthalmol. 2007 Jul. 144(1):104-108. [QxMD MEDLINE Link].
Bhandari R, Ferri S, Whittaker B, Liu M, Lazzaro DR. Peters anomaly: review of the literature. Cornea. 2011 Aug. 30(8):939-44. [QxMD MEDLINE Link].
Kim M, Lee SC, Lee SJ. Spontaneous corneal perforation in an eye with Peters' anomaly. Clin Ophthalmol. 2013. 7:1535-7. [QxMD MEDLINE Link].
Yang LL, Lambert SR, Drews-Botsch C, Stulting RD. Long-term visual outcome of penetrating keratoplasty in infants and children with Peters anomaly. J AAPOS. 2009 Apr. 13(2):175-80. [QxMD MEDLINE Link].
Chang JW, Kim JH, Kim SJ, Yu YS. Long-term clinical course and visual outcome associated with Peters' anomaly. Eye (Lond). 2012 Sep. 26(9):1237-42. [QxMD MEDLINE Link].
Sault RW, Sheridan J. Peter' anomaly. Ophthalmol Eye Dis. 2013 Feb. 13(5):1-3. [QxMD MEDLINE Link].
Hashemi H, Ghaffari R, Mohebi M. Posterior lamellar keratoplasty (DSAEK) in Peters anomaly. Cornea. 1201-5. 31(10):2012 Oct. [QxMD MEDLINE Link].
Dahl E, Koseki H, Balling R. Pax genes and organogenesis. Bioessays. 1997 Sep. 19(9):755-65. [QxMD MEDLINE Link].
Doward W, Perveen R, Lloyd IC, Ridgway AE, Wilson L, Black GC. A mutation in the RIEG1 gene associated with Peters' anomaly. J Med Genet. 1999 Feb. 36(2):152-5. [QxMD MEDLINE Link].
Krachmer JH, Mannis MJ, & Holland EJ. Cornea. 3. St. Louis: Mosby; 2011.
Gondhowiardjo TD, van Haeringen NJ. Corneal aldehyde dehydrogenase, glutathione reductase, and glutathione S-transferase in pathologic corneas. Cornea. 1993 Jul. 12(4):310-4. [QxMD MEDLINE Link].
Kivlin JD, Apple DJ, Olson RJ, Manthey R. Dominantly inherited keratitis. Arch Ophthalmol. 1986 Nov. 104(11):1621-3. [QxMD MEDLINE Link].
M Senthilkumar , V D, Punj J, Pandey R. Peters' anomaly - anaesthetic management. Indian J Anaesth. 2009 Aug. 53(4):501-3. [QxMD MEDLINE Link].
Kurilec J, Zaidman GW. Incidence of Peters anomaly and congenital corneal opacities interfering with vision in the United States. Cornea. 2014 Aug. 33(8):848-50. [QxMD MEDLINE Link].
Mayer UM. Peters' anomaly and combination with other malformations (series of 16 patients). Ophthalmic Paediatr Genet. 1992 Jul. 13(2):131-5. [QxMD MEDLINE Link].
Ozeki H, Shirai S, Nozaki M, Sakurai E, Mizuno S, Ashikari M, et al. Ocular and systemic features of Peters' anomaly. Graefes Arch Clin Exp Ophthalmol. 2000 Oct. 238(10):833-9. [QxMD MEDLINE Link].
Traboulsi EI, Maumenee IH. Peters' anomaly and associated congenital malformations. Arch Ophthalmol. 1992 Dec. 110(12):1739-42. [QxMD MEDLINE Link].
Kim YW, Choi HJ, Kim MK, Wee WR, Yu YS, Oh JY. Clinical outcome of penetrating keratoplasty in patients 5 years or younger: peters anomaly versus sclerocornea. Cornea. 2013 Nov. 32(11):1432-6. [QxMD MEDLINE Link].
Ghose S, Kishore K, Patil ND. Oculoauricular dysplasia syndrome of Goldenhar and Peters' anomaly: a new association. J Pediatr Ophthalmol Strabismus. 1992 Nov. 29(6):384-6. [QxMD MEDLINE Link].
Cibis GW, Waeltermann J, Harris DJ. Peters' anomaly in association with ring 21 chromosomal abnormality. Am J Ophthalmol. 1985 Nov. 100(5):733-4. [QxMD MEDLINE Link].
Frydman M, Weinstock AL, Cohen HA, Savir H, Varsano I. Autosomal recessive Peters anomaly, typical facial appearance, failure to thrive, hydrocephalus, and other anomalies: further delineation of the Krause-Kivlin syndrome. Am J Med Genet. 1991 Jul. 40(1):34-40. [QxMD MEDLINE Link].
Hennekam RC, Van Schooneveld MJ, Ardinger HH, Van Den Boogaard MJ, Friedburg D, Rudnik-Schoneborn S, et al. The Peters'-Plus syndrome: description of 16 patients and review of the literature. Clin Dysmorphol. 1993 Oct. 2(4):283-300. [QxMD MEDLINE Link].
Thompson EM, Winter RM, Baraitser M. Kivlin syndrome and Peters'-Plus syndrome: are they the same disorder?. Clin Dysmorphol. 1993 Oct. 2(4):301-16. [QxMD MEDLINE Link].
Reis LM1, Tyler RC, Abdul-Rahman O, Trapane P, Wallerstein R, Broome D, et al. Mutation analysis of B3GALTL in Peters Plus syndrome. Am J Med Genet A. 2008 Oct 15. 146A(20):2603-10. [QxMD MEDLINE Link].
Heinonen TY, Maki M. Peters'-plus syndrome is a congenital disorder of glycosylation caused by a defect in the beta1,3-glucosyltransferase that modifies thrombospondin type 1 repeats. Ann Med. 2009. 1(2):2-10. [QxMD MEDLINE Link].
Wertelecki W, Dev VG, Superneau DW. Abnormal centromere-chromatid apposition (ACCA) and Peters' anomaly. Ophthalmic Paediatr Genet. 1985 Aug. 6(1-2):247-55. [QxMD MEDLINE Link].
Peters Anomaly. US National Library of Medicine. Available at https://ghr.nlm.nih.gov/condition/peters-anomaly#resources. 2016 Aug 16; Accessed: June 2016.
Krachmer JH, Rodrigues MM. Posterior keratoconus. Arch Ophthalmol. 1978 Oct. 96(10):1867-73. [QxMD MEDLINE Link].
Nischal KK, Naor J, Jay V, MacKeen LD, Rootman DS. Clinicopathological correlation of congenital corneal opacification using ultrasound biomicroscopy. Br J Ophthalmol. 2002 Jan. 86(1):62-9. [QxMD MEDLINE Link].
Hirata A, Mine T. A simple and easy method using rigid endoscope to detect iridocorneal and keratolenticular adhesions in peters' anomaly. Case Rep Ophthalmol. 2013 Nov 06. 4(3):238-42. [QxMD MEDLINE Link].
Morishige N, Yamada N, Morita Y, Sonoda KH. Peters' anomaly imaged with an infrared anterior segment camera. Clin Experiment Ophthalmol. 2014 May-Jun. 42(4):391-2. [QxMD MEDLINE Link].
Matsubara A, Ozeki H, Matsunaga N, Nozaki M, Ashikari M, Shirai S, et al. Histopathological examination of two cases of anterior staphyloma associated with Peters' anomaly and persistent hyperplastic primary vitreous. Br J Ophthalmol. 2001 Dec. 85(12):1421-5. [QxMD MEDLINE Link].
Ozeki H, Shirai S, Ikeda K, Majima A, Hirabayashi Y, Yamada K. Histochemical studies on two cases of Peters' anomaly. Nippon Ganka Gakkai Zasshi. 1996 Jun. 100(6):471-7.
Cameron JA. Good visual result following early penetrating keratoplasty for Peters' anomaly. J Pediatr Ophthalmol Strabismus. 1993 Mar-Apr. 30(2):109-12. [QxMD MEDLINE Link].
Almobarak F, Khan AO. Complications and 2-year valve survival following Ahmed valve implantation during the first 2 years of life. Br J Ophthalmol. 2009 Jul. 93(7):795-8. [QxMD MEDLINE Link].
Iseri SU, Osborne RJ, Farrall M, Wyatt AW, Mirza G, Nürnberg G, et al. Seeing clearly: the dominant and recessive nature of FOXE3 in eye developmental anomalies. Hum Mutat. 2009 Oct. 30(10):1376-86. [QxMD MEDLINE Link].